Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P61278 (somatostatin)
 22,083 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The aim of this study was to gain further insight into the role that central dopaminergic pathways play in GH neuroregulation in man. Our experimental hypothesis was based on the possibility that most of the controversies on DA role could be due to the fact that the hypothalamic somatotroph rhythm (HSR) was not taken into account when interpreting the GH responses after pharmacological manipulations on dopaminergic pathways. In 10 normal subjects we monitored the effect of central dopaminergic blockade, achieved with metoclopramide (MCP; 10 mg, i.v. bolus), on the pattern of spontaneous GH secretion and the GH responses to a GHRH challenge (GRF1-29, 1 microgram/kg, i.v. bolus) administered together with MCP or 60 min after this drug was given. The study of HSR was made according to our previous postulate. Our results indicate that MCP administration, either prior to or together with the GHRH bolus, significantly increased GHRH-induced GH release during a refractory HSR phase; but not when the GHRH challenge took place during a spontaneous secretory phase. The strong relationship between pre-GHRH plasma GH values and GHRH-elicited GH peaks was lost when MCP was given. These data indicate that MCP was able to disrupt the intrinsic HSR by inhibiting the hypothalamic release of somatostatin (SS). While a main conclusion would be that central DA is a secretagogue for SS secretion, our results also suggest that this role could be dependent on its effects on the adrenergic inputs to SS neurons.
 ...
PMID:Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: studies with metoclopramide. 167 22

In the Varanus exanthematicus, the pancreatic complex comprises the true pancreas as well as an intrasplenic islet comparable to a Brockmann's body. Somatostatin content and concentration were estimated by radioimmunoassay in acetic acid extracts of both organs. Relatively large amounts of somatostatin (SLI) are present in the pancreas (2.17 +/- 0.07 micrograms) without any difference in distribution between the cranial (CP) and mediocaudal (MCP) regions. The intrasplenic islet contains as much SLI material as the whole pancreas (3.38 +/- 0.85 microgram); thus, this primitive organ presents a very high hormonal concentration (109.34 +/- 40.30 ng/mg wt). Serial dilutions of the extracts gave parallel immunoassay displacement curves and gel-filtration revealed two immunoreactive peaks: the most important one was found in the synthetic tetradecapeptide fraction, the other one near the void volume fraction. These results show an immunological similarity between the SLI substance of the pancreatic complex and the synthetic somatostatin; however, a molecular heterogeneity must not be excluded. The results are discussed from a phylogenetic point of view.
 ...
PMID:Somatostatin-like immunoreactivity in pancreatic extracts of a sahelian lizard (Varanus exanthematicus) during starvation. 613 68